LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 826

Search options

  1. Book ; Online ; E-Book: Nontuberculous mycobacterial disease

    Griffith, David E.

    a comprehensive approach to diagnosis and management

    (Respiratory medicine)

    2019  

    Author's details David E. Griffith editor
    Series title Respiratory medicine
    Language English
    Size 1 Online-Ressource (xi, 515 Seiten), Illustrationen
    Publisher Humana Press
    Publishing place Cham
    Publishing country Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019861117
    ISBN 978-3-319-93473-0 ; 9783319934723 ; 3-319-93473-2 ; 3319934724
    DOI 10.1007/978-3-319-93473-0
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: Diagnostic Criteria and the Decision to Treat Nontuberculous Mycobacterial Pulmonary Disease.

    Griffith, David E / Aksamit, Timothy R

    Clinics in chest medicine

    2023  Volume 44, Issue 4, Page(s) 757–769

    Abstract: The diagnosis of nontuberculous mycobacterial (NTM) pulmonary disease is based on three criteria: patient's symptoms, radiographic findings, and microbiologic results. The microbiologic criterion is the most complicated because it requires more than one ... ...

    Abstract The diagnosis of nontuberculous mycobacterial (NTM) pulmonary disease is based on three criteria: patient's symptoms, radiographic findings, and microbiologic results. The microbiologic criterion is the most complicated because it requires more than one positive sputum acid-fast bacilli culture. Clinicians are challenged to apply the diagnostic criteria in the context of variable patient symptoms, NTM pathogenicity, and host susceptibility. The decision to treat NTM pulmonary disease entails assessment of the risks and benefits of therapy and the patient's wishes and ability to receive treatment.
    MeSH term(s) Humans ; Nontuberculous Mycobacteria ; Mycobacterium Infections, Nontuberculous/diagnosis ; Mycobacterium Infections, Nontuberculous/drug therapy ; Lung ; Sputum/microbiology ; Lung Diseases/diagnosis ; Lung Diseases/therapy ; Lung Diseases/microbiology
    Language English
    Publishing date 2023-09-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 447455-7
    ISSN 1557-8216 ; 0272-5231
    ISSN (online) 1557-8216
    ISSN 0272-5231
    DOI 10.1016/j.ccm.2023.07.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Introducing the Nontuberculous Mycobacteria Series for CHEST.

    Griffith, David E / Daley, Charles L

    Chest

    2022  Volume 161, Issue 1, Page(s) 1–2

    MeSH term(s) Cystic Fibrosis ; Humans ; Mycobacterium Infections, Nontuberculous/diagnosis ; Mycobacterium Infections, Nontuberculous/epidemiology ; Nontuberculous Mycobacteria ; Thorax
    Language English
    Publishing date 2022-01-18
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2021.06.054
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: You Gotta Make Me See, What Does It Mean to Have an MIC?

    Griffith, David E / Winthrop, Kevin L

    Chest

    2021  Volume 159, Issue 2, Page(s) 462–464

    Language English
    Publishing date 2021-02-05
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2020.11.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Mycobacterium abscessus and Antibiotic Resistance: Same As It Ever Was.

    Griffith, David E

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2019  Volume 69, Issue 10, Page(s) 1687–1689

    MeSH term(s) Amikacin ; Anti-Bacterial Agents ; Child ; Cystic Fibrosis ; Drug Resistance, Bacterial/drug effects ; Humans ; Mycobacterium abscessus
    Chemical Substances Anti-Bacterial Agents ; Amikacin (84319SGC3C)
    Language English
    Publishing date 2019-02-06
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciz071
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Treatment of Mycobacterium avium Complex (MAC).

    Griffith, David E

    Seminars in respiratory and critical care medicine

    2018  Volume 39, Issue 3, Page(s) 351–361

    Abstract: Mycobacterium ... ...

    Abstract Mycobacterium avium
    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Bronchiectasis/diagnostic imaging ; Bronchiectasis/drug therapy ; Bronchiectasis/microbiology ; Humans ; Lung Diseases/diagnostic imaging ; Lung Diseases/drug therapy ; Lung Diseases/microbiology ; Macrolides/therapeutic use ; Microbial Sensitivity Tests ; Mycobacterium avium Complex/isolation & purification ; Mycobacterium avium-intracellulare Infection/drug therapy ; Mycobacterium avium-intracellulare Infection/microbiology ; Radiography, Thoracic ; Sputum/microbiology ; Tomography, X-Ray Computed
    Chemical Substances Anti-Bacterial Agents ; Macrolides
    Language English
    Publishing date 2018-08-02
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1183617-9
    ISSN 1098-9048 ; 1069-3424
    ISSN (online) 1098-9048
    ISSN 1069-3424
    DOI 10.1055/s-0038-1660472
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: A Nodal Immersed Finite Element-Finite Difference Method.

    Wells, David / Vadala-Roth, Ben / Lee, Jae H / Griffith, Boyce E

    Journal of computational physics

    2023  Volume 477

    Abstract: The immersed finite element-finite difference (IFED) method is a computational approach to modeling interactions between a fluid and an immersed structure. The IFED method uses a finite element (FE) method to approximate the stresses, forces, and ... ...

    Abstract The immersed finite element-finite difference (IFED) method is a computational approach to modeling interactions between a fluid and an immersed structure. The IFED method uses a finite element (FE) method to approximate the stresses, forces, and structural deformations on a
    Language English
    Publishing date 2023-01-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1469164-4
    ISSN 1090-2716 ; 0021-9991
    ISSN (online) 1090-2716
    ISSN 0021-9991
    DOI 10.1016/j.jcp.2022.111890
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Book: Mycobacterial infections

    Griffith, David E.

    (Infectious disease clinics of North America ; 16,1)

    2002  

    Author's details David E. Griffith, guest ed
    Series title Infectious disease clinics of North America ; 16,1
    Collection
    Language English
    Size IX, 254 S. : Ill., graph. Darst., Kt.
    Publisher Saunders
    Publishing place Philadelphia u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT013327037
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  9. Article ; Online: Treatment of Mycobacterium abscessus Pulmonary Disease.

    Griffith, David E / Daley, Charles L

    Chest

    2021  Volume 161, Issue 1, Page(s) 64–75

    Abstract: Mycobacterium abscessus is the second most common nontuberculous mycobacterial lung disease pathogen and comprises three subspecies: abscessus, massiliense, and bolletii. Subspecies identification is critical for disease management, as subspecies ... ...

    Abstract Mycobacterium abscessus is the second most common nontuberculous mycobacterial lung disease pathogen and comprises three subspecies: abscessus, massiliense, and bolletii. Subspecies identification is critical for disease management, as subspecies abscessus and bolletii have an inducible macrolide resistance gene [erm(41)] that results in clinical macrolide resistance. In contrast, subspecies massiliense does not have an active erm(41) gene and is therefore susceptible in vitro and clinically to macrolide-containing regimens. M abscessus is also vulnerable to acquired mutational macrolide resistance. Macrolide resistance has such a profoundly negative impact on M abscessus treatment response that preserving macrolide susceptibility with adequate companion drugs for macrolides is among the highest treatment priorities. After the macrolides, amikacin is regarded as the next most important drug for M abscessus treatment, although data validating that assertion are lacking. The considerations for preventing acquired macrolide resistance also apply to amikacin. Recent guidelines suggest that treatment should be guided by in vitro susceptibilities but, aside from macrolides and amikacin, no other antibiotics have a validated minimum inhibitory concentration for M abscessus. Currently, phase therapy (intensive and continuation) is recommended for M abscessus. This approach is successful with macrolide-susceptible M abscessus but not with macrolide-resistant M abscessus, in which even more aggressive therapy is not predictably successful. Newer drugs have become available, with encouraging in vitro activity against M abscessus, but in vivo validation of their superiority to current agents is not yet available. In the absence of unequivocally effective regimens, we offer suggestions for managing this treatment-refractory organism.
    MeSH term(s) Amikacin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Disease Management ; Drug Resistance, Bacterial/genetics ; Humans ; Macrolides/therapeutic use ; Mycobacterium Infections, Nontuberculous/drug therapy ; Mycobacterium abscessus/genetics ; Mycobacterium abscessus/pathogenicity ; Tuberculosis, Pulmonary/drug therapy
    Chemical Substances Anti-Bacterial Agents ; Macrolides ; Amikacin (84319SGC3C)
    Language English
    Publishing date 2021-07-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2021.07.035
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Tuberculosis Healthcare Workers: There Goes My Hero.

    Griffith, David E / Cegielski, J Peter

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2020  Volume 72, Issue 1, Page(s) 27–29

    MeSH term(s) Delivery of Health Care ; Health Personnel ; Humans ; Mycobacterium tuberculosis ; Triage ; Tuberculosis/drug therapy ; Tuberculosis/epidemiology
    Keywords covid19
    Language English
    Publishing date 2020-07-29
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciaa716
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top